Inhibition of protein kinase B activity induces cell cycle arrest and apoptosis during early G₁ phase in CHO cells

Cell Biol Int. 2012 Apr 1;36(4):357-65. doi: 10.1042/CBI20110092.

Abstract

Inhibition of PKB (protein kinase B) activity using a highly selective PKB inhibitor resulted in inhibition of cell cycle progression only if cells were in early G1 phase at the time of addition of the inhibitor, as demonstrated by time-lapse cinematography. Addition of the inhibitor during mitosis up to 2 h after mitosis resulted in arrest of the cells in early G1 phase, as deduced from the expression of cyclins D and A and incorporation of thymidine. After 24 h of cell cycle arrest, cells expressed the cleaved caspase-3, a central mediator of apoptosis. These results demonstrate that PKB activity in early G1 phase is required to prevent the induction of apoptosis. Using antibodies, it was demonstrated that active PKB translocates to the nucleus during early G1 phase, while an even distribution of PKB was observed through cytoplasm and nucleus during the end of G1 phase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • CHO Cells
  • Caspase 3 / genetics
  • Caspase 3 / metabolism*
  • Chlorpropamide / analogs & derivatives*
  • Chlorpropamide / pharmacology
  • Cricetinae
  • Cyclin-Dependent Kinases / genetics
  • Cyclin-Dependent Kinases / metabolism
  • Cyclins / genetics
  • Cyclins / metabolism
  • G1 Phase Cell Cycle Checkpoints / drug effects*
  • Gene Expression Regulation / drug effects
  • Mitosis / drug effects
  • Protein Kinase Inhibitors / pharmacology*
  • Protein Transport / drug effects
  • Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / drug effects
  • Thymidine / metabolism
  • Time-Lapse Imaging

Substances

  • API 2
  • Cyclins
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-akt
  • Cyclin-Dependent Kinases
  • Caspase 3
  • Thymidine
  • Chlorpropamide